Unknown

Dataset Information

0

Substitutions in PBP2b from ?-Lactam-resistant Streptococcus pneumoniae Have Different Effects on Enzymatic Activity and Drug Reactivity.


ABSTRACT: Pneumococcus resists ?-lactams by expressing variants of its target enzymes, the penicillin-binding proteins (PBPs), with many amino acid substitutions. Up to 10% of the sequence can be modified. These altered PBPs have a much reduced reactivity with the drugs but retain their physiological activity of cross-linking the peptidoglycan, the major constituent of the bacterial cell wall. However, because ?-lactams are chemical and structural mimics of the natural substrate, resistance mediated by altered PBPs raises the following paradox: how PBPs that react poorly with the drugs maintain a sufficient level of activity with the physiological substrate. This question is addressed for the first time in this study, which compares the peptidoglycan cross-linking activity of PBP2b from susceptible and resistant strains with their inhibition by different ?-lactams. Unexpectedly, the enzymatic activity of the variants did not correlate with their antibiotic reactivity. This finding indicates that some of the numerous amino acid substitutions were selected to restore a viable level of enzymatic activity by a compensatory molecular mechanism.

SUBMITTER: Calvez P 

PROVIDER: S-EPMC5314180 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Substitutions in PBP2b from β-Lactam-resistant <i>Streptococcus pneumoniae</i> Have Different Effects on Enzymatic Activity and Drug Reactivity.

Calvez Philippe P   Breukink Eefjan E   Roper David I DI   Dib Mélanie M   Contreras-Martel Carlos C   Zapun André A  

The Journal of biological chemistry 20170106 7


Pneumococcus resists β-lactams by expressing variants of its target enzymes, the penicillin-binding proteins (PBPs), with many amino acid substitutions. Up to 10% of the sequence can be modified. These altered PBPs have a much reduced reactivity with the drugs but retain their physiological activity of cross-linking the peptidoglycan, the major constituent of the bacterial cell wall. However, because β-lactams are chemical and structural mimics of the natural substrate, resistance mediated by al  ...[more]

Similar Datasets

| S-EPMC6403258 | biostudies-literature
| S-EPMC3502956 | biostudies-literature
| S-EPMC387593 | biostudies-literature
| S-EPMC3807472 | biostudies-literature
| S-EPMC2807444 | biostudies-literature
| S-EPMC4291406 | biostudies-literature
| S-EPMC1472201 | biostudies-literature
| S-EPMC10653890 | biostudies-literature
| S-EPMC7859230 | biostudies-literature
| S-EPMC1168675 | biostudies-literature